BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Department of Medicine - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/medicine
X-WR-CALDESC:Events for Department of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201015T120000
DTEND;TZID=America/New_York:20201015T130000
DTSTAMP:20260416T055449
CREATED:20201006T155701Z
LAST-MODIFIED:20201006T164013Z
UID:10001070-1602763200-1602766800@www.med.unc.edu
SUMMARY:Virtual Medicine Grand Rounds: Paul Armistead MD\, PhD and Natalie Grover\, MD - Dual Presentation
DESCRIPTION:Join us via WebEx for a dual presentation from Dr. Paul Armistead\, discussing “Targeting leukemia minor histocompatibility antigens for AML immunotherapy\,” and Dr. Natalie Grover\, discussing “Early Phase CAR-T Cell Trials at UNC.” \n  \nPaul Armistead\, MD\, PhD\nChronology\nBS Chemistry: University of North Carolina\, 1995; PhD Chemistry: University of North Carolina\, 1997-2000; MD: University of North Carolina\, 1995-1997\, 2000-2002; Intern and Resident: Brigham and Women’s Hospital\, Boston MA 2002-2005; Fellowship in Hematology / Oncology: University of Texas\, M.D. Anderson Cancer Center\, Houston TX 2005-2008; Rattay Advanced Fellows Instructorship in Stem Cell Transplant / Cancer Immunology: University of Texas\, M.D. Anderson Cancer Center\, Houston TX 2008-2009; Assistant Professor of Medicine: University of North Carolina\, 2009-2017; Associate Professor of Medicine: University of North Carolina 2017-present. \nResearch and Clinical Interests\nDr. Armistead’s clinical interests focus on hematopoietic stem cell transplant to treat leukemia\, lymphoma and multiple myeloma. This focus coincides with his research interests that focus on immune responses to hematologic malignancies and the discovery of tumor antigens for the development of immunotherapeutics. \n  \nNatalie Grover\, MD\nChronology:\nBS: Massachusetts Institute of Technology\, 2007; MD: Case Western Reserve University\, 2011; Internal Medicine Resident: University of Virginia\, 2011-2014; Hematology/Oncology Fellow: University of North Carolina\, 2014-2017; Assistant Professor of Medicine: University of North Carolina\, 2017-present. \nResearch and Clinical Interests:\nDr. Grover’s primary clinical interest is management of lymphoma. Her research interests include novel treatment strategies in lymphoma\, particularly immunotherapy\, and she is currently involved in the clinical trials of chimeric antigen receptor T-cell (CAR-T) therapy for patients with lymphoma. She is interested in innovative approaches to CAR-T therapy\, improving the efficacy of CAR-T cells\, and management and prevention of the unique toxicities associated with this therapy. Her ultimate goal is to improve therapeutic options for lymphoma patients\, while minimizing toxicities and maintaining their quality of life.
URL:https://www.med.unc.edu/medicine/event/virtual-medicine-grand-rounds-paul-armistead-md-phd-and-natalie-grover-md-dual-presentation/
LOCATION:WebEx
CATEGORIES:Educational Conferences,Medicine Grand Rounds
END:VEVENT
END:VCALENDAR